fda glp-1 compounding warning letters september 2025 GLP-1 weight loss drugs are back in the news

The FDA has sent 30 warning letters to telehealth companies for falsely marketing compounded GLP-1s, which are not FDA-approved and can pose risks to patients. FULL STORY:🔗https://tinyurl.com/3ztf9uj2

28.95

★★★★☆4.8 (126)

FDA takes aim at telehealth companies for promoting unofficial weight loss drug dupes

23.87

★★★★★4.9 (98)

Compounded Semaglutide & Tirzepatide 2025: Safe Use Guide

21.02

★★★★★5.0 (157)

Today, the FDA established a “green list” import alert to help stop potentially dangerous GLP-1 active pharmaceutical ingredients from unverified foreign sources from entering the U.S. market. The agency will continue to

20.04

★★★★★4.7 (84)

FDA Issues 30 Warning Letters to Telehealth Firms Over Misleading Compounded GLP-1 Marketing

28.56

★★★★★4.9 (203)

September 15, 2025: Telehealth company must stop implying its compounded GLP -1 is FDA-approved, warns FDA – Partnership for Safe Medicines

25.39

★★★★★5.0 (176)

ilanamuhlsteinrd Everyone is asking me about Retatrutide. I get it. The science is genuinely exciting. But let's get real; It is not FDA approved. It cannot legally be compounded. The FDA issued

24.38

★★★★★4.8 (132)